Citalopram doesn't benefit autistic children, study finds

06/2/2009 | Wall Street Journal, The

A large, government-funded trial found no evidence that citalopram, an antidepressant, minimizes repetitive behaviors in children with autism-spectrum disorders. The study showed a "placebolike response" of about 30% regardless of whether patients received citalopram or placebo for 12 weeks, researchers reported.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr Statistician I (US/TB/00/0028/SL)
Santa Clara, CA
Food & Drug Associate
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA